CURE Pharmaceutical (OTCQB: CURR) is a broad platform technology company that develops proprietary drug, nutraceutical and topical delivery systems currently holding 15 patents. The technology offers a number of unique immediate and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a technology-oriented company with its broad portfolio of patents, we will continue to develop innovative technologies for the future that will be part of the incubator strategy to monetize our intellectual property.
The Sera Labs, Inc. (“Sera Labs”), a wholly owned subsidiary of CURE, is a trusted leader in the wellness, and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical(TM), Seratopical Revolution(TM) SeraLabs(TM), and Nutri-Strips(TM). The company sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow their beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery chains, and mass retailers. For more information, visit the company’s websites at www.Seratopicalrevolution.com, www.Seratopical.com and www.Seralabshealth.com. Follow Sera Labs on Instagram at @seratopical, as well as Twitter and Facebook.
To view IBN’s virtual coverage of the 148th National Investment Banking Association (“NIBA”) Conference, visit https://ibn.fm/NIBA2022
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at NIBA’s 148th Investment Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com